How to buy Intellipharmaceutics International stock (IPCI)

Intellipharmaceutics International is an other business based in the US. Intellipharmaceutics International shares (IPCI) are listed on the NASDAQ and all prices are listed in US Dollars. Intellipharmaceutics International employs 59 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Intellipharmaceutics International stock

Buy Intellipharmaceutics International stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Intellipharmaceutics International stock price (NASDAQ: IPCI)

Use our graph to track the performance of IPCI stocks over time.

Intellipharmaceutics International shares at a glance

• Key figures

Information last updated 2021-01-22.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.00
Wall St. target price	$27.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	N/A

Is it a good time to buy Intellipharmaceutics International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Intellipharmaceutics International financials

Gross profit TTM	$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market Capitalization more info button	$0

TTM: trailing 12 months

Intellipharmaceutics International share dividends

We're not expecting Intellipharmaceutics International to pay a dividend over the next 12 months.

Intellipharmaceutics International overview

IntelliPharmaCeutics International Inc. , a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada. It develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Oxycodone ER, an abuse deterrent oxycodone hydrochloride extended release tablets; Regabatin and Lyrica pregabalin extended-release capsules for the management of neuropathic pain; Effexor XR, an extended-release capsule for oral administration to treat depression; Protonix, a delayed-release capsule for oral administration to treat gastroesophageal reflux disease; and Glucophage XR, a drug that treats type 2 diabetes. It also provides Seroquel XR, an oral psychotropic agent for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; Lamictal XR, an anticonvulsant drug to terat epilepsy; Keppra XR, an antiepileptic drug for the treatment of partial onset seizures in patients with epilepsy; Pristiq, a selective serotonin and norepinephrine reuptake inhibitor to treat major depressive disorder; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company provides Focalin XR, an extended-release capsule for hyperactivity disorder. It has has a license and commercialization agreement with Par Pharmaceutical Inc.

Frequently asked questions

null
How many people work for Intellipharmaceutics International?
Latest data suggests 59 work at Intellipharmaceutics International. When does the fiscal year end for Intellipharmaceutics International?
Intellipharmaceutics International's fiscal year ends in November. Where is Intellipharmaceutics International based?
Intellipharmaceutics International's address is: 30 Worcester Road M9W 5X2,Toronto,CAN What is Intellipharmaceutics International's ISIN number?
Intellipharmaceutics International's international securities identification number is: CA4581733090 What is Intellipharmaceutics International's CUSIP number?
Intellipharmaceutics International's Committee on Uniform Securities Identification Procedures number is: 458173309